CLINICAL POSTER HIGHLIGHTSNasopharyngeal Carriage of Streptococcus pneumoniae: Epidemiology and Influence of Vaccination

A supplement to Pediatric News.
Funding for this supplement was provided by Wyeth Pharmaceuticals, Collegeville, PA.
This supplement was developed from scientific information presented at the 2009 European Society for Pediatric Infectious Diseases (ESPID) convened in Brussels, Belgium, June 9-13, 2009.

Topic Highlights

• Introduction
• Risk Factors for Bacterial Nasopharyngeal Carriage and the Effect of PCV7
• Changes in Carriage of Streptococcus pneumoniae in Children Attending Day Care Centres (DCCs) in Coimbra, Portugal
• Dynamic Epidemiology of Nasopharyngeal Flora in Kindergarten Children
• Prevalence of Streptococcus pneumoniae Nasal Carriage Among Children With Community Acquired Respiratory Tract Infections
• Effect of a Reduced Dose Infant Schedule of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) on Nasopharyngeal Pneumococcal Carriage (NP-PNC-CARR)
• Nasopharyngeal Microbiota During Upper Respiratory Infection: Comparison Between Children With and Without Acute Otitis Media

Faculty/Faculty Disclosures

Ron Dagan, MD
Professor of Pediatrics and Infectious Disease
Pediatric Infectious Disease Unit
Soroka University Medical Center
Facility of Health Sciences
Ben-Gurion University of the Negev, Beer-Sheva, Israel
Dr. Dagan discloses that in the past 48 months, he has been a scientific consultant for Berna/Crucell, GlaxoSmithKline, Merck, Novartis, Protea, and Wyeth; has been a speaker for Berna/Crucell, GlaxoSmithKline, and Wyeth; has received grant or research support from Berna/Crucell, Merck, and Wyeth; and is a shareholder in Protea.
 

Copyright © 2009 by Elsevier Inc.

To view the supplement, click the image above.

A supplement to Pediatric News.
Funding for this supplement was provided by Wyeth Pharmaceuticals, Collegeville, PA.
This supplement was developed from scientific information presented at the 2009 European Society for Pediatric Infectious Diseases (ESPID) convened in Brussels, Belgium, June 9-13, 2009.

Topic Highlights

• Introduction
• Risk Factors for Bacterial Nasopharyngeal Carriage and the Effect of PCV7
• Changes in Carriage of Streptococcus pneumoniae in Children Attending Day Care Centres (DCCs) in Coimbra, Portugal
• Dynamic Epidemiology of Nasopharyngeal Flora in Kindergarten Children
• Prevalence of Streptococcus pneumoniae Nasal Carriage Among Children With Community Acquired Respiratory Tract Infections
• Effect of a Reduced Dose Infant Schedule of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) on Nasopharyngeal Pneumococcal Carriage (NP-PNC-CARR)
• Nasopharyngeal Microbiota During Upper Respiratory Infection: Comparison Between Children With and Without Acute Otitis Media

Faculty/Faculty Disclosures

Ron Dagan, MD
Professor of Pediatrics and Infectious Disease
Pediatric Infectious Disease Unit
Soroka University Medical Center
Facility of Health Sciences
Ben-Gurion University of the Negev, Beer-Sheva, Israel
Dr. Dagan discloses that in the past 48 months, he has been a scientific consultant for Berna/Crucell, GlaxoSmithKline, Merck, Novartis, Protea, and Wyeth; has been a speaker for Berna/Crucell, GlaxoSmithKline, and Wyeth; has received grant or research support from Berna/Crucell, Merck, and Wyeth; and is a shareholder in Protea.
 

Copyright © 2009 by Elsevier Inc.

To view the supplement, click the image above.

A supplement to Pediatric News.
Funding for this supplement was provided by Wyeth Pharmaceuticals, Collegeville, PA.
This supplement was developed from scientific information presented at the 2009 European Society for Pediatric Infectious Diseases (ESPID) convened in Brussels, Belgium, June 9-13, 2009.

Topic Highlights

• Introduction
• Risk Factors for Bacterial Nasopharyngeal Carriage and the Effect of PCV7
• Changes in Carriage of Streptococcus pneumoniae in Children Attending Day Care Centres (DCCs) in Coimbra, Portugal
• Dynamic Epidemiology of Nasopharyngeal Flora in Kindergarten Children
• Prevalence of Streptococcus pneumoniae Nasal Carriage Among Children With Community Acquired Respiratory Tract Infections
• Effect of a Reduced Dose Infant Schedule of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) on Nasopharyngeal Pneumococcal Carriage (NP-PNC-CARR)
• Nasopharyngeal Microbiota During Upper Respiratory Infection: Comparison Between Children With and Without Acute Otitis Media

Faculty/Faculty Disclosures

Ron Dagan, MD
Professor of Pediatrics and Infectious Disease
Pediatric Infectious Disease Unit
Soroka University Medical Center
Facility of Health Sciences
Ben-Gurion University of the Negev, Beer-Sheva, Israel
Dr. Dagan discloses that in the past 48 months, he has been a scientific consultant for Berna/Crucell, GlaxoSmithKline, Merck, Novartis, Protea, and Wyeth; has been a speaker for Berna/Crucell, GlaxoSmithKline, and Wyeth; has received grant or research support from Berna/Crucell, Merck, and Wyeth; and is a shareholder in Protea.
 

Copyright © 2009 by Elsevier Inc.

To view the supplement, click the image above.